Testing effectiveness (Phase 2)Study completedNCT05052697
What this trial is testing
Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza
Who this might be right for
Influenza, Human
Pfizer 1,158
Showing 20 of 0 results